Hans de Jong

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Patient Reported Outcomes

Ultrasound Guided

Prostate Cancer

Radical Prostatectomy

Top Venues

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Wieke C H Visser, Hans de Jong, Sandra Steyaert, Willem J G Melchers, Peter F A Mulders, Jack A Schalken
Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer. Prostate cancer and prostatic diseases 25 (3) (2022)
Rianne J Hendriks, Marloes M G van der Leest, Bas Israël, Gerjon Hannink, Anglita YantiSetiasti, Erik B Cornel, Christina A Hulsbergen-van de Kaa, O Sjoerd Klaver, J P Michiel Sedelaar, Wim Van Criekinge, Hans de Jong, Peter F A Mulders, E David Crawford, Jeroen Veltman, Jack A Schalken, Jelle O Barentsz, Inge M van Oort
Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men. Prostate cancer and prostatic diseases 24 (4) (2021)
Wieke C H Visser, Hans de Jong, Willem J G Melchers, Peter F A Mulders, Jack A Schalken
Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis. Cancers 12 (12) (2020)